{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:08:06Z","timestamp":1782871686064,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1124\/dmd.109.027292","type":"journal-article","created":{"date-parts":[[2009,6,9]],"date-time":"2009-06-09T00:47:25Z","timestamp":1244508445000},"page":"1806-1818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Bioactivation of Minocycline to Reactive Intermediates by Myeloperoxidase, Horseradish Peroxidase, and Hepatic Microsomes: Implications for Minocycline-Induced Lupus and Hepatitis"],"prefix":"10.1016","volume":"37","author":[{"given":"Baskar","family":"Mannargudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McNally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Uetrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.109.027292_bib1","first-page":"518","article-title":"[Minocycline hypersensitivity syndrome]","volume":"126","author":"Antunes","year":"1999","journal-title":"Ann Dermatol Venereol"},{"key":"10.1124\/dmd.109.027292_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1422.019","article-title":"Drug-induced lupus","volume":"1108","author":"Borchers","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/dmd.109.027292_bib3","first-page":"1873","article-title":"Fulminant hepatic failure, hepatorenal syndrome, and necrotizing pancreatitis after minocycline hepatotoxicity","volume":"25","author":"Boudreaux","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1124\/dmd.109.027292_bib4","first-page":"1208","article-title":"Minocycline therapy in acne vulgaris","volume":"17","author":"Cullen","year":"1976","journal-title":"Cutis"},{"key":"10.1124\/dmd.109.027292_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1021\/tx960150g","article-title":"Mechanism for the anti-thyroid action of minocycline","volume":"10","author":"Doerge","year":"1997","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.109.027292_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1046\/j.1365-2133.2000.03357.x","article-title":"Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome","volume":"142","author":"Dunphy","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1124\/dmd.109.027292_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1177\/106002809703101009","article-title":"Minocycline-induced lupus","volume":"31","author":"Farver","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1124\/dmd.109.027292_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2230.1996.tb00077.x","article-title":"Minocycline and hepatitis","volume":"21","author":"Hardman","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1124\/dmd.109.027292_bib9","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jps.2600590824","article-title":"Quantitative spectrophotometric methods for determination of sodium hypochlorite in aqueous solutions","volume":"59","author":"Hussain","year":"1970","journal-title":"J Pharm Sci"},{"key":"10.1124\/dmd.109.027292_bib10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1044-0305(02)00356-2","article-title":"Mass spectral characterization of tetracyclines by electrospray ionization, H\/D exchange, and multiple stage mass spectrometry","volume":"13","author":"Kamel","year":"2002","journal-title":"J Am Soc Mass Spectrom"},{"key":"10.1124\/dmd.109.027292_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1996.03890320082013","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1124\/dmd.109.027292_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ACI.0b013e3283079c64","article-title":"The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity","volume":"8","author":"Lavergne","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1124\/dmd.109.027292_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2165\/00002018-200023040-00006","article-title":"Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data","volume":"23","author":"Lawrenson","year":"2000","journal-title":"Drug Saf"},{"key":"10.1124\/dmd.109.027292_bib14","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/S0021-9258(20)82244-3","article-title":"The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature","volume":"239","author":"Omura","year":"1964","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.027292_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1398-9995.1990.tb00502.x","article-title":"Serum sickness-like syndrome associated with minocycline therapy","volume":"45","author":"Puyana","year":"1990","journal-title":"Allergy"},{"key":"10.1124\/dmd.109.027292_bib16","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/00912700122010753","article-title":"The risk of liver damage associated with minocycline: a comparative study","volume":"41","author":"Seaman","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/dmd.109.027292_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.109.027292_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archinte.159.5.493","article-title":"Minocycline and lupuslike syndrome in acne patients","volume":"159","author":"Sturkenboom","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1124\/dmd.109.027292_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpedi.152.11.1132","article-title":"Minocycline-related autoimmune hepatitis: case series and literature review","volume":"152","author":"Teitelbaum","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1124\/dmd.109.027292_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.autrev.2005.01.002","article-title":"Current trends in drug-induced autoimmunity","volume":"4","author":"Uetrecht","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1124\/dmd.109.027292_bib21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03602539208996297","article-title":"The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions","volume":"24","author":"Uetrecht","year":"1992","journal-title":"Drug Metab Rev"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624021548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624021548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.109.027292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:42:07Z","timestamp":1739896927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624021548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0090955624021548"],"URL":"https:\/\/doi.org\/10.1124\/dmd.109.027292","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioactivation of Minocycline to Reactive Intermediates by Myeloperoxidase, Horseradish Peroxidase, and Hepatic Microsomes: Implications for Minocycline-Induced Lupus and Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.109.027292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}